Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Wed Apr 02 20:32:00 GMT 2025
by
admin
on
Wed Apr 02 20:32:00 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | ALLOGENIC HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | blood |
| Fraction Material Type | cells |
| Fraction Name | vgamma9vdelta2 t-cell receptor cells |
| Record UNII |
9B6H5Y8CA4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9B6H5Y8CA4
Created by
admin on Wed Apr 02 20:32:00 GMT 2025 , Edited by admin on Wed Apr 02 20:32:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
under development for the treatment of relapsed or refractory acute myeloid leukaemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia (CLL) and multiple myeloma, myelodysplastic syndrome, chronic myelomonocytic leukemia (CMML), myeloproliferative neoplasms and ovarian cancer.
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CULTURE | GROWTH FACTOR | BIOLOGICAL | HUMAN INTERLEUKIN-2 | FNO32LO217 | |
| CULTURE | CELLULAR SELECTION | DIFFERENTION | ZOLEDRONIC ACID | 6XC1PAD3KF |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| HLA MATCH | GENETIC IDENTITY' |
|